Objective This study aimed to examine whether diabetes mellitus is causally associated with
osteonecrosis. Method Using publicly accessible genome-wide association study statistics …

Objective The magnitude of the mortality benefit conferred by good integral metabolic control
in diabetes in not sufficiently known, especially among Latin American patients. We …

Background: Limited research has been conducted to quantitatively assess the impact of
systemic inflammation in metabolic dysfunction-associated fatty liver disease (MAFLD) and …

Low levels of high‐density lipoprotein‐cholesterol (HDL‐C) is considered a major
cardiovascular risk factor. However, recent studies have suggested a more U‐shaped …

Objective Coronary artery disease (CAD) and type 2 diabetes (T2DM) are closely associated
with increased rate of death. C1q/TNF-related protein 6 (CTRP6) is a novel adipocytokine …

Background Coronary heart disease (CHD) is the most important complication of type 2
diabetes mellitus (T2DM) and the leading cause of death. Identifying the risk of CHD in …

Background Diabetes mellitus (DM) and its cardiovascular disease (CVD) complication are
among the most frequent causes of death worldwide. However, the metabolites linking up …

Aims To identify physical activity trajectories, explore the factors associated with them and
assess their relationship with all-cause mortality. Methods This was a population-based …

Aims. The cardiobenefits of empagliflozin are multidimensional, and some mechanisms are
still unclear. The aim of the present study was to evaluate the effect of treatment with …

Background: The glucagon-like peptide 1 receptor agonist (GLP-1RA) is an antidiabetic
medication with vascular protection and anti-inflammatory properties. Theoretically, the use …